Skip to main content

Infographic: Europe’s potential for biotech innovation

Europe has world-class universities, research institutions, medical centers, and hospitals that provide a strong base for sourcing and developing scientific innovation. However, this strength does not yet translate into patents for new medicines, as Europe trails both China and the United States in that area. Increased investment in biotech may hold the key to helping grow Europe’s share of new drugs. Europe’s biotechs currently receive only 20 percent of the funding their US counterparts do. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
Building European biotech sector with world-class science and innovation
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

Related Articles